Tavapadon

Clicks: 2
ID: 338664
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #248 of 255 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 255 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
AHFS CLASS: 28:36.20.08 Nonergot-derivative Dopamine Receptor Agonists Brand: Juvmo® Tavapadon is a nonergot-derivative dopamine receptor agonist. Tavapadon is indicated for the treatment of Parkinson’s disease in adults. Tavapadon is available in the following dosage form(s) and strength(s): Tablets: 0.25 mg, 1 mg, 5 mg, 10 mg, and 15 mg It is essential that the manufacturer's labeling be consulted for more detailed information on dosage and administration of this drug. Dosage summary: ... None. Patients with Parkinson's disease may have an impaired capacity to respond to an orthostatic challenge. In clinical studies and clinical experience, dopaminergic medications appear to impair the systemic regulation of blood pressure, resulting in hypotension and/or orthostatic hypotension, especially during dose escalation. For these reasons, patients with Parkinson's disease being treated with tavapadon should be monitored for signs and symptoms of hypotension/orthostatic hypotension especially during dose escalation, and should be informed of this risk.
Reference Key
openalex_W7225247291 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag354
URL
https://doi.org/10.1093/ajhp/zxag354
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.